Hermann JM, Miller KM, Hofer SE et al (2020) The Transatlantic HbA1c gap: differences in glycaemic control across the lifespan between people included in the US T1D Exchange Registry and those included in the German/Austrian DPV registry. Diabet Med 37(5):848–55. https://doi.org/10.1111/dme.14148

Article  CAS  PubMed  Google Scholar 

Centers for Disease Control and Prevention (2022) National Diabetes Statistics Report | Report 1: Care processes and treatment targets, detailed analysis report. CDC National Diabetes Audit 2021-22.Availble from www.cdc.gov/diabetes/data/statistics-report/index.html. Accessed 1 March 2024

International Diabetes Federation (2019) IDF Diabetes Atlas 9th Edition 2019. Available from https://diabetesatlas.org/idfawp/resource-files/2019/07/IDF_diabetes_atlas_ninth_edition_en.pdf

Phillip M, Nimri R, Bergenstal RM et al (2023) Consensus recommendations for the use of automated insulin delivery technologies in clinical practice. Endocr Rev 44(2):254–280. https://doi.org/10.1210/endrev/bnac022

Article  PubMed  Google Scholar 

Jiao X, Shen Y, Chen Y (2022) Better TIR, HbA1c, and less hypoglycemia in closed-loop insulin system in patients with type 1 diabetes: a meta-analysis. BMJ Open Diabetes Res Care 10(2):e002633. https://doi.org/10.1136/bmjdrc-2021-002633

Article  PubMed  PubMed Central  Google Scholar 

Karageorgiou V, Papaioannou TG, Bellos I et al (2019) Effectiveness of artificial pancreas in the non-adult population: a systematic review and network meta-analysis. Metabolism 90:20–30. https://doi.org/10.1016/j.metabol.2018.10.002

Article  CAS  PubMed  Google Scholar 

Bekiari E, Kitsios K, Thabit H et al (2018) Artificial pancreas treatment for outpatients with type 1 diabetes: systematic review and meta-analysis. BMJ 361:k1310. https://doi.org/10.1136/bmj.k1310

Article  PubMed  PubMed Central  Google Scholar 

Ekhlaspour L, Town M, Raghinaru D, Lum JW, Brown SA, Buckingham BA (2022) Glycemic outcomes in baseline hemoglobin a1c subgroups in the International Diabetes Closed-Loop trial. Diabetes Technol Ther 24(8):588–91. https://doi.org/10.1089/dia.2021.0524

Article  CAS  PubMed  PubMed Central  Google Scholar 

Beck RW, Kanapka LG, Breton MD et al (2023) A meta-analysis of randomized trial outcomes for the t:slim X2 insulin pump with Control-IQ technology in youth and adults from age 2 to 72. Diabetes Technol Ther 25(5):329–42. https://doi.org/10.1089/dia.2022.0558

Article  PubMed  PubMed Central  Google Scholar 

Bally L, Thabit H, Ruan Y et al (2018) Bolusing frequency and amount impacts glucose control during hybrid closed-loop. Diabet Med 35(3):347–51. https://doi.org/10.1111/dme.13436

Article  CAS  PubMed  Google Scholar 

Castañeda J, Mathieu C, Aanstoot H-J et al (2022) Predictors of time in target glucose range in real-world users of the MiniMed 780G system. Diabetes Obes Metab 24(11):2212–21. https://doi.org/10.1111/dom.14807

Article  CAS  PubMed  Google Scholar 

Daly AB, Boughton CK, Nwokolo M et al (2023) Fully automated closed-loop insulin delivery in adults with type 2 diabetes: an open-label, single-center, randomized crossover trial. Nat Med 29(1):203–8. https://doi.org/10.1038/s41591-022-02144-z

Article  CAS  PubMed  PubMed Central  Google Scholar 

Boughton CK, Tripyla A, Hartnell S et al (2021) Fully automated closed-loop glucose control compared with standard insulin therapy in adults with type 2 diabetes requiring dialysis: an open-label, randomized crossover trial. Nat Med 27(8):1471–6. https://doi.org/10.1038/s41591-021-01453-z

Article  CAS  PubMed  PubMed Central  Google Scholar 

Bally L, Thabit H, Hartnell S et al (2018) Closed-loop insulin delivery for glycemic control in noncritical care. N Engl J Med 379(6):547–56. https://doi.org/10.1056/NEJMoa1805233

Article  CAS  PubMed  Google Scholar 

Boughton CK, Bally L, Martignoni F et al (2019) Fully closed-loop insulin delivery in inpatients receiving nutritional support: a two-centre, open-label, randomised controlled trial. Lancet Diabetes Endocrinol 7(5):368–77. https://doi.org/10.1016/S2213-8587(19)30061-0

Article  CAS  PubMed  PubMed Central  Google Scholar 

Levy CJ, Raghinaru D, Kudva YC et al (2024) Beneficial effects of Control-IQ automated insulin delivery in basal-bolus and basal-only insulin users with type 2 diabetes. Clin Diabetes 42(1):116–24. https://doi.org/10.2337/cd23-0025

Article  PubMed  Google Scholar 

Davis GM, Peters AL, Bode BW et al (2023) Safety and efficacy of the Omnipod 5 automated insulin delivery system in adults with type 2 diabetes: from injections to hybrid closed-loop therapy. Diabetes Care 46(4):742–50. https://doi.org/10.2337/dc22-1915

Article  PubMed  PubMed Central  Google Scholar 

Sherwood JS, Castellanos LE, O’Connor MY et al (2024) Randomized trial of the insulin-only iLet Bionic Pancreas for the treatment of cystic fibrosis- related diabetes. Diabetes Care 47(1):101–8. https://doi.org/10.2337/dc23-1411

Article  PubMed  Google Scholar 

Speight J, Choudhary P, Wilmot EG et al (2023) Impact of glycaemic technologies on quality of life and related outcomes in adults with type 1 diabetes: a narrative review. Diabet Med 40(1):e14944. https://doi.org/10.1111/dme.14944

Article  PubMed  Google Scholar 

Godoi A, Reis Marques I, Padrão EMH et al (2023) Glucose control and psychosocial outcomes with use of automated insulin delivery for 12 to 96 weeks in type 1 diabetes: a meta-analysis of randomised controlled trials. Diabetol Metab Syndr 15(1):190. https://doi.org/10.1186/s13098-023-01144-4

Article  CAS  PubMed  PubMed Central  Google Scholar 

Kimbell B, Rankin D, Hart RI et al (2022) Parents’ experiences of using a hybrid closed-loop system (CamAPS FX) to care for a very young child with type 1 diabetes: qualitative study. Diabetes Res Clin Pract 187:109877. https://doi.org/10.1016/j.diabres.2022.109877

Article  PubMed  Google Scholar 

Rankin D, Kimbell B, Hovorka R, Lawton J (2022) Adolescents’ and their parents’ experiences of using a closed-loop system to manage type 1 diabetes in everyday life: qualitative study. Chronic Illn 18(4):742–56. https://doi.org/10.1177/1742395320985924

Article  CAS  PubMed  Google Scholar 

Gianini A, Suklan J, Skela-Savič B et al (2022) Patient reported outcome measures in children and adolescents with type 1 diabetes using advanced hybrid closed loop insulin delivery. Front Endocrinol 13:967725. https://doi.org/10.3389/fendo.2022.967725

Article  Google Scholar 

Cobry EC, Bisio A, Wadwa RP, Breton MD (2022) Improvements in parental sleep, fear of hypoglycemia, and diabetes distress with use of an advanced hybrid closed-loop system. Diabetes Care 45(5):1292–5. https://doi.org/10.2337/dc21-1778

Article  PubMed  PubMed Central  Google Scholar 

Lawton J, Kimbell B, Closs M et al (2023) Listening to women: experiences of using closed-loop in type 1 diabetes pregnancy. Diabetes Technol Ther 25(12):845–55. https://doi.org/10.1089/dia.2023.0323

Article  PubMed  PubMed Central  Google Scholar 

Akturk HK, Agarwal S, Hoffecker L, Shah VN (2021) Inequity in racial-ethnic representation in randomized controlled trials of diabetes technologies in type 1 diabetes: critical need for new standards. Diabetes Care 44(6):e121–e123. https://doi.org/10.2337/dc20-3063

Article  PubMed  PubMed Central  Google Scholar 

Bergenstal RM, Nimri R, Beck RW et al (2021) A comparison of two hybrid closed-loop systems in adolescents and young adults with type 1 diabetes (FLAIR): a multicentre, randomised, crossover trial. Lancet 397(10270):208–19. https://doi.org/10.1016/S0140-6736(20)32514-9

Article  CAS  PubMed  PubMed Central  Google Scholar 

Brown SA, Kovatchev BP, Raghinaru D et al (2019) Six-month randomized, multicenter trial of closed-loop control in type 1 diabetes. N Engl J Med 381(18):1707–17. https://doi.org/10.1056/NEJMoa1907863

Article  CAS  PubMed  PubMed Central  Google Scholar 

Benhamou PY, Franc S, Reznik Y et al (2019) Closed-loop insulin delivery in adults with type 1 diabetes in real-life conditions: a 12-week multicentre, open-label randomised controlled crossover trial. Lancet Digit Health 1(1):e17–e25. https://doi.org/10.1016/S2589-7500(19)30003-2

Article